CLOZAPINE IN TREATMENT OF SCHIZOPHRENIA
Author(s):
Anjum F. Saudagar, Dhanraj N. Wasmate, Shyamlila B. Bavage, Nandkishor B. Bavage
Keywords:
Antipsychotic, Schizophrenia, Extrapyramidal symptoms, adverse effect and Baseline pathology.
Abstract
Clozapine is antipsychotic mediation which is mostly used in patients with treatment resistant schizophrenia and against the negative symptoms .In it the clinical response of 84 schizophrenic patients were examined, previous antipsychotic medication had been withdrawn, and patient were treated with clozapine according to standardization titration, we also observe the adverse effects, extrapyramidal symptoms , baseline pathology and literature of reviews. After all, these variables may have important for the use if clozapine and our understanding of the pathophysiology if treatment resistant – schizophrenia.
Article Details
Unique Paper ID: 152362

Publication Volume & Issue: Volume 8, Issue 3

Page(s): 12 - 19
Article Preview & Download


Share This Article

Conference Alert

NCSST-2021

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2021

SWEC- Management

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2021

Go To Issue



Call For Paper

Volume 8 Issue 4

Last Date 25 September 2021

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews

Contact Details

Telephone:6351679790
Email: editor@ijirt.org
Website: ijirt.org

Policies